Cargando…
Gb3/cd77 Is a Predictive Marker and Promising Therapeutic Target for Head and Neck Cancer
Head and neck squamous cell carcinoma is the sixth leading cancer in the world. This cancer is difficult to treat and is characterized by recurrences that are often fatal. This cancer is generally removed surgically, but it often regrows from the edges of the lesion from where most recurrences reapp...
Autores principales: | García-Hevia, Lorena, Muñoz-Guerra, Débora, Casafont, Íñigo, Morales-Angulo, Carmelo, Ovejero, Victor J., Lobo, David, Fanarraga, Mónica L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029501/ https://www.ncbi.nlm.nih.gov/pubmed/35453483 http://dx.doi.org/10.3390/biomedicines10040732 |
Ejemplares similares
-
Magnetic lipid nanovehicles synergize the controlled thermal release of chemotherapeutics with magnetic ablation while enabling non-invasive monitoring by MRI for melanoma theranostics
por: García-Hevia, Lorena, et al.
Publicado: (2021) -
Shiga Toxin Receptor Gb3Cer/CD77: Tumor-Association and Promising Therapeutic Target in Pancreas and Colon Cancer
por: Distler, Ute, et al.
Publicado: (2009) -
Targeting Nanomaterials to Head and Neck Cancer Cells Using a Fragment of the Shiga Toxin as a Potent Natural Ligand
por: Navarro-Palomares, Elena, et al.
Publicado: (2021) -
Microtubule cytoskeleton-disrupting activity of MWCNTs: applications in cancer treatment
por: Hevia, Lorena García, et al.
Publicado: (2020) -
Evaluation of an amino acid residue critical for the specificity and activity of human Gb3/CD77 synthase
por: Kaczmarek, Radoslaw, et al.
Publicado: (2016)